Rakuten Securities’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Buy
+21
New +$11.8K ﹤0.01% 450
2026
Q1
Sell
-40
Closed -$19.5K 958
2025
Q4
$19.5K Buy
40
+10
+33% +$4.66K 0.01% 337
2025
Q3
$12.6K Sell
30
-76
-72% -$25.6K ﹤0.01% 374
2025
Q2
$30.5K Buy
106
+46
+77% +$13.7K 0.01% 271
2025
Q1
$18.5K Hold
60
0.01% 327
2024
Q4
$21.2K Buy
60
+50
+500% +$18.4K 0.01% 299
2024
Q3
$3.58K Sell
10
-14
-58% -$4.73K ﹤0.01% 455
2024
Q2
$7.64K Buy
24
+17
+243% +$4.5K ﹤0.01% 357
2024
Q1
$1.61K Sell
7
-63
-90% -$14.2K ﹤0.01% 518
2023
Q4
$15.4K Buy
+70
New +$16.1K 0.01% 254

Other funds holding UTHR

Rakuten Securities's UTHR Position: Q2 2026 in Review

Rakuten Securities opened a new position in United Therapeutics (UTHR) in Q2 2026: 21 shares worth $11.4K. The stake represents ﹤0.01% of the portfolio and ranks #450 among its holdings. This is a return to the name: Rakuten Securities previously reported a position in UTHR as recently as Q4 2025.

Rakuten Securities first reported a position in UTHR in Q4 2023 and has held it in 10 quarters since. The position peaked at $30.5K in Q2 2025. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Rakuten Securities held 21 shares of United Therapeutics worth $11.4K as of Q2 2026.
  • United Therapeutics was a new Rakuten Securities position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #450 holding.
  • Rakuten Securities first reported a position in United Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • Rakuten Securities's United Therapeutics position peaked at $30.5K in Q2 2025.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.